Microfluidic paper-based analytical devices (μPADs) have garnered significant interest as a
promising analytical platform in the past decade. Compared with traditional microfluidics …

Heart failure (HF) remains a major public health concern, with a prevalence of more than 5.8
million in the United States and more than 23 million worldwide. 1 With an aging population …

Heart failure (HF) is the end-stage of cardiovascular diseases, which is associated with a
high mortality rate and high readmission rate. Household early diagnosis and real-time …

Objectives: The aim of this study was to perform a meta-analysis of currently available data
regarding the prognostic significance of soluble suppression of tumorigenecity–2 (sST2) …

Background—Underlying mechanisms in heart failure (HF) with preserved ejection fraction
remain unknown. We investigated cardiovascular plasma biomarkers in HF with preserved …

Background—Heart failure with preserved ejection fraction is a clinical syndrome that has
been associated with changes in the extracellular matrix. The purpose of this study was to …

Soluble suppression of tumorigenicity-2 (sST2) is a biomarker widely investigated during the
last few years. Its role has become clear in pathological conditions such as fibrosis and …

Heart failure (HF) with preserved ejection fraction (HFpEF) is a heterogeneous clinical
syndrome characterized by cardiovascular, metabolic, and pro‐inflammatory diseases …

Abstract Objective Circulating microRNAs (miRNAs) have been implicated in both heart
failure and atherosclerotic disease. The aim of this study was to examine associations …

The prevalence of heart failure with preserved ejection fraction (HFpEF) is steadily
increasing. Its diagnosis remains difficult and controversial and relies mostly on non …